Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,052,319 papers from all fields of science
Search
Sign In
Create Free Account
sucroferric oxyhydroxide 500 MG Chewable Tablet
Known as:
SUCROFERRIC OXYHYDROXIDE 500MG CHEW TAB
, SUCROFERRIC OXYHYDROXIDE 500MG TAB,CHEW
, SUCROFERRIC OXYHYDROXIDE 500MG TAB,CHEW [VA Product]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Chewable Tablet
Phosphate Chelating Activity [MoA]
sucroferric oxyhydroxide
Narrower (1)
sucroferric oxyhydroxide 500 MG Chewable Tablet [Velphoro]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
SP610REAL-WORLD IMPROVEMENTS IN SERUM PHOSPHORUS CONTROL AMONG HAEMODIALYSIS PATIENTS TREATED WITH SUCROFERRIC OXYHYDROXIDE: A RETROSPECTIVE DATABASE ANALYSIS OF FOUR EUROPEAN COUNTRIES
A. Benedetto
,
R. Ramos
,
+5 authors
S. Stuard
Nephrology, Dialysis and Transplantation
2019
Corpus ID: 196552138
2018
2018
[Pharmacological, pharmaceutical and clinical profiles of sucroferric oxyhydroxide (P-TOL® Chewable Tab. 250 mg, 500 mg), a therapeutic agent for hyperphosphatemia].
S. Tatemichi
,
Fumiaki Nakagaki
,
S. Yoshioka
,
Natsuko Shichiri
Nihon yakurigaku zasshi. Folia pharmacologica…
2018
Corpus ID: 4554364
Sucroferric oxyhydroxide (P-TOL® chewable tablets, 250 and 500 mg) is a phosphate binder for oral use; it is composed of…
Expand
2017
2017
Comparative analysis of the phosphate-binding effects of sucroferric oxyhydroxide, ferric citrate, and lanthanum carbonate
Takeo Ishii
,
Y. Nakajima
,
Kunio Oyama
Renal Replacement Therapy
2017
Corpus ID: 42180184
BackgroundIron-based phosphate binders are widely used in hemodialysis, to avoid the increased mortality associated with high…
Expand
2017
2017
Efficacy and Safety of Sucroferric Oxyhydroxide in Hispanic Dialysis Patients
S. Sprague
,
M. Henriquez
,
+5 authors
M. Ketteler
2017
Corpus ID: 80580671
2016
2016
Supplementary Material for: Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients
S. Sprague
,
A. Covic
,
+4 authors
A. Rastogi
2016
Corpus ID: 99332020
2015
2015
POST HOC ANALYSIS OF ANTIANEMIC AGENT USE OVER 1 YEAR IN A PHASE 3 STUDY OF SUCROFERRIC OXYHYDROXIDE
S. Sprague
,
A. Covic
,
+5 authors
M. Ketteler
2015
Corpus ID: 76436745
2015
2015
FP383POST HOC ANALYSIS OF IV IRON AND ESA USE OVER 1 YEAR IN A PHASE 3 STUDY OF SUCROFERRIC OXYHYDROXIDE
A. Covic
,
S. Sprague
,
+5 authors
J. Flöge
2015
Corpus ID: 73966680
Review
2014
Review
2014
Tackling non-adherence in dialysis patients with hyperphosphataemia
V. Rakov
,
E. Chong
,
J. Parker
2014
Corpus ID: 72194597
Many patients with late-stage chronic kidney disease require oral phosphate binders to control serum phosphorus levels. However…
Expand
2008
2008
New opportunities of variation in the particle sizes and properties of chromium dioxide
M. Osmolowsky
,
O. Bondarenko
,
S. V. Gordeev
,
A. Y. Otkupshchikov
,
S. I. Korolev
,
A. I. Kobelev
2008
Corpus ID: 115130535
It is experimentally found that clusters containing 24 W or Mo atoms act as initial nuclei in CrO2 crystallization. Joint…
Expand
2006
2006
Thermochemistry of the chromium hydroxides Cr(OH)n, n = 2-6, and the oxyhydroxide CrO(OH)4: ab initio predictions.
I. Nielsen
,
M. Allendorf
Journal of Physical Chemistry A
2006
Corpus ID: 24092808
We here present a high-level ab initio study of the thermochemistry of the chromium hydroxides Cr(OH)n, n = 2-6, and of the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE